Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Johnson AM, Barsky M, Ahmed W, Zullow S, Galati J, Jairath V, Narula N, Peerani F, Click BH, Coburn ES, Dang TT, Gold S, Agrawal M, Garg R, Aggarwal M, Mohammad D, Halloran B, Kochhar GS, Todorowski H, Ud Din NM, Izanec J, Teeple A, Gasink C, Muser E, Ding Z, Swaminath A, Lakhani K, Hogan D, Datta S, Ungaro RC, Boland BS, Bohm M, Fischer M, Sagi S, Afzali A, Ullman T, Lawlor G, Baumgart DC, Chang S, Hudesman D, Lukin D, Scherl EJ, Colombel JF, Sands BE, Siegel CA, Regueiro M, Sandborn WJ, Bruining D, Kane S, Loftus EV Jr, Dulai PS. Johnson AM, et al. Among authors: click bh. Am J Gastroenterol. 2023 Feb 1;118(2):317-328. doi: 10.14309/ajg.0000000000002047. Epub 2022 Sep 30. Am J Gastroenterol. 2023. PMID: 36191274
Constructing an Inflammatory Bowel Disease Patient-Centered Medical Home.
Regueiro M, Click B, Holder D, Shrank W, McAnallen S, Szigethy E. Regueiro M, et al. Clin Gastroenterol Hepatol. 2017 Aug;15(8):1148-1153.e4. doi: 10.1016/j.cgh.2017.05.026. Epub 2017 Jun 16. Clin Gastroenterol Hepatol. 2017. PMID: 28624253 No abstract available.
Ileocecal Anastomosis Type Significantly Influences Long-Term Functional Status, Quality of Life, and Healthcare Utilization in Postoperative Crohn's Disease Patients Independent of Inflammation Recurrence.
Gajendran M, Bauer AJ, Buchholz BM, Watson AR, Koutroubakis IE, Hashash JG, Ramos-Rivers C, Shah N, Lee KK, Cruz RJ, Regueiro M, Zuckerbraun B, Schwartz M, Swoger J, Barrie A, Harrison J, Hartman DJ, Salgado J, Rivers WM, Click B, Anderson AM, Umapathy C, Babichenko D, Dunn MA, Binion DG. Gajendran M, et al. Am J Gastroenterol. 2018 Apr;113(4):576-583. doi: 10.1038/ajg.2018.13. Epub 2018 Mar 6. Am J Gastroenterol. 2018. PMID: 29610509
Managing Risks with Biologics.
Click B, Regueiro M. Click B, et al. Curr Gastroenterol Rep. 2019 Jan 11;21(2):1. doi: 10.1007/s11894-019-0669-6. Curr Gastroenterol Rep. 2019. PMID: 30635807 Review.
Targeting anti-fibrotic pathways in Crohn's disease - The final frontier?
Ma C, Jairath V, Click B, Hirota SA, Lu C, Parker CE, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Ma C, et al. Best Pract Res Clin Gastroenterol. 2019 Feb-Apr;38-39:101603. doi: 10.1016/j.bpg.2019.02.005. Epub 2019 Feb 16. Best Pract Res Clin Gastroenterol. 2019. PMID: 31327400 Review.
72 results